Inspire Medical Systems, Inc. (INSP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Acceswire
2025.08.10 15:00
portai
I'm PortAI, I can summarize articles.

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors of Inspire Medical Systems, Inc. (INSP) following a significant stock drop of 40.6% after the company reported Q2 earnings and lowered its revenue guidance. The investigation focuses on delays in the rollout of the "Inspire V" system due to billing issues with Medicare. Investors are encouraged to assist the investigation by contacting the firm.

NEW YORK CITY, NY / ACCESS Newswire / August 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inspire Medical Systems, Inc. ("Inspire" or "the Company") . Investors who purchased Inspire securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INSP.

Investigation Details

On August 4, 2025, Inspire reported Q2 earnings, lowering its full-year revenue guidance and disclosing delays in the rollout of its "Inspire V" system. The Company revealed that treatment centers had postponed the adoption of its new system due to not being able to bill Medicare until July 1, 2025. Following this news, Inspire stock dropped almost 40.6% in intraday trading on August 5, 2025.

What's Next?

If you are aware of any facts relating to this investigation or purchased Inspire securities, you can assist this investigation by visiting the firm's site: bgandg.com/INSP. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Nathan Miller

332-239-2660 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

View the original press release on ACCESS Newswire